Hussman Strategic Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-20,615
Closed -$958K 201
2019
Q1
$958K Hold
20,615
0.23% 153
2018
Q4
$1.01M Hold
20,615
0.24% 158
2018
Q3
$1.28M Sell
20,615
-12,570
-38% -$764K 0.37% 115
2018
Q2
$1.79M Sell
33,185
-31,425
-49% -$1.57M 0.48% 94
2018
Q1
$2.94M Sell
64,610
-64,107
-50% -$2.75M 0.81% 52
2017
Q4
$5.06M Sell
128,717
-62,850
-33% -$2.39M 1.45% 7
2017
Q3
$7.06M Hold
191,567
1.71% 3
2017
Q2
$7.38M Buy
191,567
+62,850
+49% +$2.3M 1.63% 7
2017
Q1
$4.38M Buy
128,717
+125,700
+4,166% +$4.13M 0.97% 37
2016
Q4
$99K Buy
+3,017
New +$97.9K 0.02% 148

Other funds holding EHC

Hussman Strategic Advisors's EHC Position: Q2 2019 in Review

Hussman Strategic Advisors sold out of Encompass Health (EHC) in Q2 2019, closing a stake of 20,615 shares — an estimated $958K sold.

Hussman Strategic Advisors first reported a position in EHC in Q4 2016 and held it in 10 quarters. The position peaked at $7.38M in Q2 2017. 395 funds tracked by Wall St. Rank hold EHC as of Q2 2019.

  • Hussman Strategic Advisors reported no remaining Encompass Health position as of Q2 2019 after selling out during the quarter.
  • Hussman Strategic Advisors sold 20,615 Encompass Health shares in Q2 2019, an estimated $958K.
  • Hussman Strategic Advisors first reported a position in Encompass Health in Q4 2016 and held it in 10 quarters.
  • Hussman Strategic Advisors's Encompass Health position peaked at $7.38M in Q2 2017.
  • 395 funds tracked by Wall St. Rank held Encompass Health as of Q2 2019.

Based on Hussman Strategic Advisors's 13F filing for Q2 2019, filed 31 Jul 2019.